WARRINGTON, Pa., Aug. 11, 2010 (GLOBE NEWSWIRE) -- Discovery Laboratories, Inc. (Nasdaq:DSCO) announces today that Dr. Thomas F. Miller, Senior Vice President of Commercial & Corporate Development of Discovery Labs, will present an overview of the Company at the 2010 Global Hunter Securities Healthcare Conference taking place at the SCIC (Southern California Investor Conference) on August 17, 2010 in Newport Beach, CA. The conference will be simultaneously webcast over the Internet. Dr. Miller is scheduled to present at 3:30 PM PDT (6:30 PM EDT) on Tuesday, August 17, 2010. The presentation will be available through a live audio webcast at http://events.powerstream.net/002/00584/20100817_SCIC_Discovery/or at Discovery Labs' web site, www.discoverylabs.com. A replay of the audio webcast will be available on both websites for sixty days. About Discovery Labs Discovery Laboratories, Inc. is a biotechnology company developing KL4 surfactant therapies for respiratory diseases. Surfactants are produced naturally in the lungs and are essential for breathing. Discovery Labs' novel proprietary KL4 surfactant technology produces a synthetic, peptide-containing surfactant that is structurally similar to pulmonary surfactant and is being developed in liquid, aerosol or lyophilized formulations. In addition, Discovery Labs' proprietary capillary aerosolization technology produces a dense aerosol, with a defined particle size that is capable of potentially delivering aerosolized KL4 surfactant to the deep lung without the complications currently associated with liquid surfactant administration. Discovery Labs believes that its proprietary technology platform makes it possible, for the first time, to develop a significant pipeline of surfactant products to address a variety of respiratory diseases for which there frequently are few or no approved therapies. For more information, please visit our website at www.Discoverylabs.com.
CONTACT: Discovery Laboratories, Inc. John G. Cooper, EVP and Chief Financial Officer 215-488-9300